Given his focal neurologic symptoms (e.g., left facial drooping and left hemiparesis), bilateral carotid bruit, and no evidence of intracranial bleed on head CT, the patient was empirically started on thrombolytic therapy (i.e., tissue plasminogen activator, tPA) for presumed stroke. This evidence concerns the gene PLAT and stroke disorder.